Our innovative technology was compared in a bioavailability study of EPA and DHA (the essential omega 3 fatty acids) with common softgels. The results suggested a 44% higher bioavailability of our technology compared to traditional formats such as softgels.
Due to this unique emulsification technology, our active ingredients dissolve evenly in the intestinal liquids, due to larger surface contact. This results in better conditions for gastric enzymes and as a result in a much higher ingredients bioavailability.
